These novel variants further expanded the existing spectrum of HARS2 variants and phenotypes of Perrault syndrome or SNHL, which can assist in molecular diagnosis and genetic counselling of patients with SNHL. This evidence concerns the gene HARS2 and Perrault syndrome.